सभी अध्ययन
भर्तीPhase IVहस्तक्षेपात्मक

DEsogestrel for Bleeding on the Implant (DEBI)

This study, called DEBI, aims to find a better way to help people who experience frustrating bleeding while using the contraceptive implant. The implant is highly effective at preventing pregnancy, but many people have it removed early due to period problems. We're comparing desogestrel, a hormone-only tablet, with the combined oral contraceptive pill (COCP), which contains two hormones. Desogestrel might be safer, cheaper, and easier to access for some. The research wants to see if desogestrel is just as good as the COCP in stopping problem bleeding within 90 days. If it is, it could provide a new, improved treatment option for many implant users.

एक नजर में

स्थिति
भर्ती
चरण
Phase IV
प्रायोजक
नॉटिंघम विश्वविद्यालय
नामांकन लक्ष्य
690
प्रारंभ
30 सितम्बर 2025
अनुमानित पूर्णता
30 Apr 2027

यह अध्ययन किस बारे में है?

The contraceptive implant is a small rod placed under the skin of your arm that's incredibly good at preventing pregnancy – more than 99% effective. However, a common issue for some people using it is bothersome and unpredictable bleeding or spotting. This can be so frustrating that about a quarter of users decide to have their implant removed early, which can sometimes lead to unplanned pregnancies.

Currently, doctors often suggest taking the combined oral contraceptive pill (COCP) to try and sort out this bleeding. Our study is looking at another treatment option: desogestrel. This is a "mini-pill" that only contains one type of hormone, unlike the COCP which has two. Desogestrel might be a more suitable option for some people, especially those who can't take the combined pill or prefer not to. It's also potentially safer and more affordable, and doesn't require the regular blood pressure and weight checks needed for the combined pill.

The main goal of this research is to see if desogestrel is just as good as the combined pill at reducing problem bleeding within 90 days. If it is, it could mean a simpler, safer, and easier-to-get treatment for people struggling with bleeding while on the implant. This could help more people continue using this very effective form of contraception.

मुख्य निष्कर्ष

  • Exploring new ways to manage problematic bleeding with the contraceptive implant.
  • Comparing desogestrel (mini-pill) with the combined pill (COCP).
  • Aims to find a safer, simpler, and more accessible treatment.
  • Participation involves taking daily tablets and keeping a bleeding diary for 90 days.
  • No extra clinic visits needed; designed to be easy for participants.

कौन पात्र हो सकता है?

This study is looking for around 690 people who are currently using the contraceptive implant and are experiencing bothersome bleeding. You need to be between 16 and 45 years old and have had your implant in for at least 3 months but no longer than 24 months.

"Problem bleeding" simply means any bleeding (like spotting or heavy bleeding) that you find disruptive or concerning. You'll need to be willing to keep a daily diary of your bleeding throughout the study.

There are some reasons why you might not be able to join, such as if you recently used certain medications or hormones that affect your period, have had certain types of surgery, or have specific medical conditions. The study team will check all these details carefully to make sure the study is right for you.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. Are you between 16 and 45 years old?
  2. Do you currently have a contraceptive implant?
  3. Has your implant been in for at least 3 months, but no more than 2 years?
  4. Are you experiencing bleeding with your implant that you find problematic?
  5. Are you willing to keep a daily bleeding diary?
  6. Can you provide your informed consent to participate?
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

If you join the study, you'll be randomly given either desogestrel tablets or combined oral contraceptive pill tablets to take. You'll take these tablets daily for 90 days.

The main thing you'll need to do is keep a simple daily diary about your bleeding throughout this period. The study has been designed to reduce the time commitment for you, so these daily diaries and a few short questions about taking your medication will be the main task. There aren't any extra doctor's appointments or follow-up visits needed for the study beyond your usual care. The total active participation in terms of taking medication and recording information will be mainly for the 90 days.

संभावित जोखिम और लाभ

Taking part in this study could help us find a better, simpler treatment for implant-related bleeding, potentially benefiting many people in the future. You will receive either desogestrel or the combined pill, which are both established medications for contraception. However, in this study, they are being used specifically to manage implant-related bleeding. Both medications have known side effects, which will be fully explained to you in detail by the study doctor and in the patient information sheets. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

स्थान (25)

  • नॉटिंघम यूनिवर्सिटी हॉस्पिटल्स एनएचएस ट्रस्ट
    केवल शहर
    Nottingham, England
  • Leeds Community Healthcare NHS Trust
    अनुमानित
    लीड्स, इंग्लैंड
  • Cambridgeshire Community Services NHS Trust
    केवल शहर
    St. Ives, England
  • University Hospitals Sussex NHS Foundation Trust
    केवल शहर
    Worthing, England
  • हैम्पशायर और आइल ऑफ वाइट हेल्थकेयर एनएचएस फाउंडेशन ट्रस्ट
    केवल शहर
    Southampton, England
  • University of Nottingham Health Service
    असत्यापित
    Nottingham, England
  • Kingston and Richmond NHS Foundation Trust
    असत्यापित
    Kingston upon Thames, England
  • Northamptonshire Healthcare NHS Foundation Trust
    असत्यापित
    Kettering, England
  • यूनिवर्सिटी हॉस्पिटल्स बर्मिंघम एनएचएस फाउंडेशन ट्रस्ट
    असत्यापित
    Birmingham, England
  • लिवरपूल यूनिवर्सिटी हॉस्पिटल्स एनएचएस फाउंडेशन ट्रस्ट
    असत्यापित
    लिवरपूल, इंग्लैंड
  • London North West University Healthcare NHS Trust
    असत्यापित
    Harrow, England
  • The Royal Wolverhampton NHS Trust
    असत्यापित
    Wolverhampton, England

सामान्य प्रश्न

What is the contraceptive implant?

It's a small, flexible rod placed under the skin of your arm that releases hormones to prevent pregnancy for up to 3 years. It's very effective.

What kind of bleeding is considered 'problem bleeding'?

It's any bleeding, like spotting or heavy periods, that you personally find frustrating or bothersome while using your implant.

क्या मुझे पता चलेगा कि मुझे कौन सा उपचार मिल रहा है?

The study is 'blinded', meaning you won't know if you're taking desogestrel or the combined pill until the study is over. This helps ensure fair results.

Do I have to visit the clinic often?

No, there are no extra follow-up visits specifically for the study, beyond any appointments you'd usually have with your doctor.

अगर मैं भाग लेने के बारे में अपना मन बदल लूँ तो क्या होगा?

You are free to leave the study at any point, and you don't need a reason. Your usual medical care will not be affected.

और अधिक जानने के लिए कैसे पता करें

Jo Brooks

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

भाग लेने में रुचि रखते हैं?

अपनी रुचि दर्ज करें

अपने विवरण साझा करें और अनुसंधान टीम के लिए "DEsogestrel for Bleeding on the Implant (DEBI)…यदि आप पात्र हो सकते हैं तो आपसे संपर्क करेंगे। भाग लेने के लिए सहमति देने से पहले हमेशा अपने जीपी से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.